Survey data suggests that over a third of organizations that relied on US funding for HIV services had already closed by ...

AstraZeneca’s EsoBiotec acquisition is the latest in a series of deals struck by the pharma giant to secure a place in the next wave of cell therapies for cancer and immune-mediated diseases.

Prime Editing has potential to be best-in-class approach for AATD ---- Previously undisclosed program now emerging from within liver platform; ...

Kiromic BioPharma has put 31 people on furlough. The cell therapy biotech has stopped paying the employees, which make up “substantially all” of its workforce, until it raises money to ease its cash ...

Explore the promising potential of Altimmune, Inc.'s Pemvidutide in NASH, AUD, & obesity treatment, with key trials underway.

Bill Gates, co-chair of the Bill and Melinda Gates Foundation, on Monday met Union Agriculture Minister Shivraj Singh Chouhan ...

When exploring exemptions to patent infringement, there are several key Federal Circuit cases to be aware of. First, we will ...

Incyte has delivered a pair of pivotal wins for an oral JAK inhibitor in an inflammatory skin condition. But with the placebo ...

It looks like SoftBank's Vision Fund 2 is coming back strong. In the last nearly two quarters, the fund has participated in ...

Aquaculture stands as one of the most extensive and economically valuable human activities in marine environments, serving as a crucial source of protein in ...

DES MOINES, Iowa, March 17, 2025 /PRNewswire/ -- Biospace.com, the leading life science news and careers site, is celebrating its 30 th anniversary, marking three decades of innovation, industry ...

On March 5, the US Court of Appeals for the Federal Circuit issued a decision in Lashify, Inc. v. International Trade Commission, No.